MDxHealth (MDXH) Earnings Analysis

MDxHealth (MDXH) next reports earnings on 2026-08-13, consensus EPS -0.19336 USD. Last quarter (2025-11-12) it missed with EPS -0.16 USD vs -0.10686 USD est (-49.7%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -0.65.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MDXH next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.19336 USD
Revenue estimate0.03B

MDXH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-11-12-0.16 USD-0.10686 USD-49.7%Miss
2024-08-21-0.31 USD-0.26 USD-19.2%Miss

Beat rate: 0/2 (0%) over reported quarters with consensus data.

MDXH valuation and analyst view

Trailing P/E-0.65
Trailing EPS-0.52265 USD
Price / book-1.81
Dividend yield0.00%
Market cap0.02B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)
Avg price target4 USD

Related research pages

Frequently asked questions

When is MDxHealth (MDXH)'s next earnings date?

MDxHealth is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.19336 USD and revenue estimate of 0.03B.

Did MDXH beat earnings last quarter?

In its 2025-11-12 report, MDXH posted EPS of -0.16 USD versus a -0.10686 USD estimate — a miss of 49.7%.

What is MDXH's earnings track record?

Over the last 2 reported quarters with consensus data, MDXH beat estimates 0 times (0%).

What is MDXH's current P/E ratio and EPS?

MDXH trades at a trailing P/E of -0.65 on trailing EPS of -0.5226473175021987 USD.

What do analysts rate MDXH?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 4 USD.